OFIX Orthofix Medical Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: OFIX

Price (delayed)

$11.05

Market cap

$406.16M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.9

Enterprise value

$461.91M

Orthofix Medical Inc. is a global medical device and biologics company with a spine and extremities focus. The Company's mission is to deliver innovative, quality-driven solutions as it partners with ...

Highlights
The revenue is up by 44% year-on-year and by 12% since the previous quarter
The gross profit has increased by 29% year-on-year and by 9% since the previous quarter
The equity has soared by 85% YoY but it has contracted by 3.8% from the previous quarter
The net income has plunged by 200% YoY and by 15% from the previous quarter
The EPS has plunged by 70% YoY and by 7% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.orthofix.com
Peers: ATEC SYK GMED

Key stats

What are the main financial stats of OFIX
Market
Shares outstanding
36.76M
Market cap
$406.16M
Enterprise value
$461.91M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.66
Price to sales (P/S)
0.62
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.69
Earnings
Revenue
$668.46M
EBIT
-$129.26M
EBITDA
-$82.74M
Free cash flow
-$89.61M
Per share
EPS
-$3.9
Free cash flow per share
-$2.41
Book value per share
$16.75
Revenue per share
$17.95
TBVPS
$15.84
Balance sheet
Total assets
$905.65M
Total liabilities
$290.17M
Debt
$89.41M
Equity
$615.48M
Working capital
$241.17M
Liquidity
Debt to equity
0.15
Current ratio
2.58
Quick ratio
0.97
Net debt/EBITDA
-0.67
Margins
EBITDA margin
-12.4%
Gross margin
65.6%
Net margin
-20.4%
Operating margin
-19.7%
Efficiency
Return on assets
-17.1%
Return on equity
-24.2%
Return on invested capital
-31.1%
Return on capital employed
-17.2%
Return on sales
-19.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

OFIX stock price

How has the Orthofix Medical stock price performed over time
Intraday
-1.87%
1 week
-2.47%
1 month
0.18%
1 year
-38.58%
YTD
-46.18%
QTD
-14.07%

Financial performance

How have Orthofix Medical's revenue and profit performed over time
Revenue
$668.46M
Gross profit
$438.82M
Operating income
-$131.84M
Net income
-$136.28M
Gross margin
65.6%
Net margin
-20.4%
The net income has plunged by 200% YoY and by 15% from the previous quarter
Orthofix Medical's net margin has plunged by 108% YoY and by 3.6% from the previous quarter
The revenue is up by 44% year-on-year and by 12% since the previous quarter
The gross profit has increased by 29% year-on-year and by 9% since the previous quarter

Growth

What is Orthofix Medical's growth rate over time

Valuation

What is Orthofix Medical stock price valuation
P/E
N/A
P/B
0.66
P/S
0.62
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.69
The EPS has plunged by 70% YoY and by 7% from the previous quarter
The equity has soared by 85% YoY but it has contracted by 3.8% from the previous quarter
The stock's price to book (P/B) is 67% less than its 5-year quarterly average of 2.0 and 34% less than its last 4 quarters average of 1.0
The price to sales (P/S) is 59% lower than the 5-year quarterly average of 1.5 and 38% lower than the last 4 quarters average of 1.0
The revenue is up by 44% year-on-year and by 12% since the previous quarter

Efficiency

How efficient is Orthofix Medical business performance
OFIX's ROE has shrunk by 79% YoY
OFIX's return on assets has dropped by 74% year-on-year
The ROS has contracted by 3.8% from the previous quarter
The ROIC has grown by 3.1% from the previous quarter

Dividends

What is OFIX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OFIX.

Financial health

How did Orthofix Medical financials performed over time
The company's total liabilities has surged by 150% YoY and by 11% QoQ
The total assets has surged by 101% year-on-year
Orthofix Medical's debt is 85% less than its equity
OFIX's debt to equity has soared by 150% YoY and by 36% from the previous quarter
The equity has soared by 85% YoY but it has contracted by 3.8% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.